Buy Sun Pharma, price target Rs 430: Gaurav Ratnaparkhi

The analyst suggested a stoploss at Rs 360.

Shutterstock.com

Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 94377.84 Crore) operating in Pharmaceuticals sector.

Gaurav Ratnaparkhi of Sharekhan has a buy call on Sun Pharmaceutical Industries Ltd. with a target price of Rs 430.0 . The current price of Sun Pharmaceutical Industries Ltd. is Rs 403.0 . Gaurav Ratnaparkhi recommended to keep a stoploss at Rs 360 .

Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 94377.84 Crore) operating in Pharmaceuticals sector.

Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 9783.29 Crore to Sales Value (94.95 % of Total Sales) and Other Operating Revenue which contributed Rs 519.92 Crore to Sales Value (5.04 % of Total Sales)for the year ending 31-Mar-2019.


For the quarter ended 31-12-2019, the company has reported a Consolidated sales of Rs 8038.65 Crore, up 1.13 % from last quarter Sales of Rs 7949.19 Crore and up 4.99 % from last year same quarter Sales of Rs 7656.71 Crore Company has reported net profit after tax of Rs 1023.71 Crore in latest quarter.
ADVERTISEMENT
READ MORE

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

Related Companies

More from our Partners

Loading next story
Business News › Markets › Stocks › Recos › Buy Sun Pharma, price target Rs 430: Gaurav Ratnaparkhi
Text Size:AAA
Success
This article has been saved

*

+